Something Special is Brewing at GSK Biopharm

Published on :

Something Special is Brewing at GSK Biopharm November 20, 2019 Last week GSK Biopharm, the large-scale biomanufacturing half of GSK’s Rockville, MD operation, sponsored BioBuzz at local brewery, True Respite. In addition to celebrating the near-completion of their $139M expansion, they had a clear message to share with the BioHealth Capital Region.  Something special is [….]

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™

Published on :

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™ November 20, 2018 Leadiant Biosciences, Inc. formerly known as Sigma-Tau Pharmaceuticals, recently received FDA approval for Revcovi™, which provides improved treatment for patients living with ADA-SCID, better known as “Bubble Boy Disease.” The journey that lead to Revcovi is a prime example of [….]

RoosterBio’s Got Plenty to Crow About

Published on :

RoosterBio’s Got Plenty to Crow About First in the ‘Plug and Play’ Stem Cell Products RoosterBio has come a long way from its days in the FITCI incubator. In 2013, five people worked in a single small space. Now there is more than enough room for the current team of thirty-five, a common area, kitchen [….]

Cell Therapy to Replace All Modern Medicine?

Published on :

CELL THERAPY TO REPLACE ALL MODERN MEDICINE? In order: Phil Vanek, PhD (GE Healthcare); Claudia Zylberberg, PhD (Akron Biotechnology); Joshua Hare, MD (Longeveron); Doug Doerfler (Maxcyte) participate in the “Realizing the Potential of Stem Cell Therapies” panel at the TEDCO Entrepeneur Expo November 9, 2018   The TEDCO Stem Cell Symposium included several speakers and [….]

Viela Bio’s Spinout Story Reveals A Roadmap for Growth Ahead

Published on :

Viela Bio’s Spinout Story Reveals A Roadmap for Growth Ahead November 6, 2018 In order: Elizabeth Parsons (Member, Mintz Levin), Aaron Ren (Head of BD and Operations, Viela Bio), Christian Dinneen-Long (Senior Council, AstraZeneca), and Chris Jeffers (Member, Mintz Levin), participate in panel discussion at TEDCO’s Entrepreneur Expo on the Viela Bio Corporate Spinout Story [….]

Maryland’s World Leading Cell Therapy Industry Showcased at TEDCO’s Stem Cell Symposium & Entrepreneur Expo

Published on :

Maryland’s World Leading Cell Therapy Industry Showcased at TEDCO’s Stem Cell Symposium & Entrepreneur Expo Dan Gincel, Executive Director of the MSCRF (Maryland Stem Cell Research Fund), kicked off the 10th annual Stem Cell Symposium which has combined to be part of the Annual TEDCO Entrepreneur Expo for the past two years. The event attracted [….]

Baltimore High School Science Team Wins Bronze in International Genetic Engineering Competition

Published on :

Baltimore High School Science Team Wins Bronze in International Genetic Engineering Competition A science team of 15 high schoolers from Baltimore, THE BALTIMORE BIO-CREW, won “Best Presentation” award, and took home an overall Bronze in the annual international genetic engineering competition at MIT; iGEM.  Their research used genetically engineered enzymes from viper venom to induce blood [….]

CRB Shares Commitment to Building up the Region at Oktoberfest Open House Event

Published on :

CRB Shares Commitment to Building up the Region at Oktoberfest Open House Event October 24, 2018 Every October BioBuzz hosts “the Science of Beer”, an Oktoberfest themed event with a local Brewer, and for the past three years CRB has been the sponsor for this fan favorite. Over the years we partnered with breweries like [….]

Baltimore’s Gemstone Biotherapeutics Poised to Transform Wound Care Market

Published on :

Baltimore’s Gemstone Biotherapeutics Poised to Transform Wound Care Market October 16, 2018 In the U.S. alone, there are over 100 million chronic wound visits every year. By 2020, the general wound care market is expected to hit about $20.5 billion. Maryland’s Gemstone Biotherapeutics aims to address this market with a highly tunable, novel biosynthetic wound [….]

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on :

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular, has generated more local excitement in the BioHealth Capital Region than any other; that is [….]